A patient with stage IV uterine cancer displaying circulating tumor cells and high microsatellite instability who had rejected standard chemotherapy and immune-check-point inhibitor treatment received monotherapy with autologous formalin-fixed tumor vaccine (AFTV). The treatment resulted in shrinkage of multiple lung metastases, suggesting that AFTV will be an attractive treatment option.